Plasminogen activator inhibitor-1 polymorphism is associated with increased risk for oral cancer
- 31 October 2006
- journal article
- Published by Elsevier BV in Oral Oncology
- Vol. 42 (9), 888-892
- https://doi.org/10.1016/j.oraloncology.2005.12.005
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Genome‐wide profiling of oral squamous cell carcinomaThe Journal of Pathology, 2004
- Host-derived plasminogen activator inhibitor-1 (PAI-1) concentration is critical for in vivo tumoral angiogenesis and growthOncogene, 2004
- Urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1: novel tumor-derived factors with a high prognostic and predictive impact in breast cancerThrombosis and Haemostasis, 2004
- The PAI-I gene 4G/5G Polymorphism and Deep Vein Thrombosis in Patients with Inherited ThrombophiliaClinical and Applied Thrombosis/hemostasis, 2003
- Plasminogen activator inhibitor-1 gene polymorphism and colorectal cancer risk and prognosisCancer Letters, 2003
- Molecular pathogenesis of oral squamous carcinomaMolecular Pathology, 2000
- Human oral squamous cell carcinoma cell lines promote angiogenesis via expression of vascular endothelial growth factor and upregulation of KDR/flk-1 expression in endothelial cellsOral Oncology, 1999
- The urokinase-type plasminogen activator system in cancer metastasis: A reviewInternational Journal of Cancer, 1997
- A NOVEL G/A AND THE 4G/5G POLYMORPHISM WITHIN THE PROMOTER OF THE PLASMINOGEN ACTIVATOR INHIBITOR-1 GENE IN PATIENTS WITH DEEP VEIN THROMBOSISThrombosis Research, 1996
- Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction.Proceedings of the National Academy of Sciences, 1995